PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 223 filers reported holding PDL BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 2.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $395,000 | -72.3% | 111,491 | -60.7% | 0.35% | -23.4% |
Q3 2015 | $1,427,000 | +659.0% | 283,754 | +868.4% | 0.46% | +197.4% |
Q2 2015 | $188,000 | -25.7% | 29,300 | -18.6% | 0.16% | -26.9% |
Q1 2015 | $253,000 | +3.7% | 36,000 | +13.6% | 0.21% | 0.0% |
Q4 2014 | $244,000 | +95.2% | 31,700 | +89.8% | 0.21% | +61.8% |
Q3 2014 | $125,000 | -41.9% | 16,700 | -24.8% | 0.13% | -28.0% |
Q2 2014 | $215,000 | – | 22,200 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Argent Trust Co | 41,405 | $102,270 | 0.01% |
Diversified Trust Co | 11,029 | $26,469 | 0.00% |
HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
Ancora Advisors LLC | 4,948 | $0 | 0.00% |
Westside Investment Management, Inc. | 500 | $0 | 0.00% |